Alpha 2.0
Login Register
» Authors » April Sisson

April Sisson

Explore the profile of April Sisson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 129
Followers 0
Related Specialties
Neurology
Cardiology & Vascular Diseases
General Medicine
Top 10 Co-Authors
Andrei V Alexandrov
Anne W Alexandrov
Reza Bavarsad Shahripour
Karen C Albright
Pawan V Rawal
Amelia K Boehme
Michael J Lyerly
Niren Kapoor
Muhammad Alvi
Kristian Barlinn
Published In
Stroke
J Stroke Cerebrovasc Dis
Stroke Res Treat
South Med J
J Neurol Disord Stroke
Affiliations
Soon will be listed here.
Recent Articles
1.
Patient Selection for Drip and Ship Thrombolysis in Acute Ischemic Stroke
Lyerly M, Albright K, Boehme A, Shahripour R, Donnelly J, Houston J, et al.
South Med J . 2015 Jul; 108(7):393-8. PMID: 26192934
Objectives: The drip and ship model is a method used to deliver thrombolysis to acute stroke patients in facilities lacking onsite neurology coverage. We sought to determine whether our drip...
2.
Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt
Boehme A, Rawal P, Lyerly M, Albright K, Shahripour R, Palazzo P, et al.
J Stroke Cerebrovasc Dis . 2014 Aug; 23(8):2001-2006. PMID: 25113079
Background: To assess the utility of previously developed scoring systems, we compared SEDAN, named after the components of the score (baseline blood Sugar, Early infarct signs and (hyper) Dense cerebral...
3.
Safety of intravenous tissue plasminogen activator administration with computed tomography evidence of prior infarction
Lyerly M, Houston J, Boehme A, Albright K, Shahripour R, Palazzo P, et al.
J Stroke Cerebrovasc Dis . 2014 Apr; 23(6):1657-61. PMID: 24685993
Background: Prior stroke within 3 months excludes patients from thrombolysis; however, patients may have computed tomography (CT) evidence of prior infarct, often of unknown time of origin. We aimed to...
4.
Hemorrhagic Transformation (HT) and Symptomatic Intracerebral Hemorrhage (sICH) Risk Prediction Models for Postthrombolytic Hemorrhage in the Stroke Belt
Siegler J, Alvi M, Boehme A, Lyerly M, Albright K, Shahripour R, et al.
ISRN Stroke . 2014 Feb; 2013:681673. PMID: 24504047
Background: Symptomatic intracerebral hemorrhage (sICH) remains the most feared complication of intravenous tissue plasminogen activator (IV tPA) treatment. We aimed to investigate how previously validated scoring methodologies would perform in...
5.
The Potential Impact of Maintaining a 3-Hour IV Thrombolysis Window: How Many More Patients can we Safely Treat?
Lyerly M, Albright K, Boehme A, Shahripour R, Houston J, Rawal P, et al.
J Neurol Disord Stroke . 2014 Jan; 1(2):1015. PMID: 24471140
Background: In 2008, the European Cooperative Acute Stroke Study-3 (ECASS-3) demonstrated that intravenous-tissue plasminogen activator could be safely administered for acute stroke patients presenting between 3 and 4.5 hours from...
6.
Predictors of systemic inflammatory response syndrome in ischemic stroke undergoing systemic thrombolysis with intravenous tissue plasminogen activator
Boehme A, Kapoor N, Albright K, Lyerly M, Rawal P, Shahripour R, et al.
J Stroke Cerebrovasc Dis . 2014 Jan; 23(4):e271-6. PMID: 24424334
Background: Systemic inflammatory response syndrome (SIRS) is an inflammatory process associated with poor outcomes in acute ischemic stroke (AIS) patients. However, no study to date has investigated predictors of SIRS...
7.
CLOTBUST-Hands Free: pilot safety study of a novel operator-independent ultrasound device in patients with acute ischemic stroke
Barreto A, Alexandrov A, Shen L, Sisson A, Bursaw A, Sahota P, et al.
Stroke . 2013 Oct; 44(12):3376-81. PMID: 24159060
Background And Purpose: The Combined Lysis of Thrombus in Brain Ischemia With Transcranial Ultrasound and Systemic T-PA-Hands-Free (CLOTBUST-HF) study is a first-in-human, National Institutes of Health-sponsored, multicenter, open-label, pilot safety...
8.
Safety of protocol violations in acute stroke tPA administration
Lyerly M, Albright K, Boehme A, Shahripour R, Houston J, Rawal P, et al.
J Stroke Cerebrovasc Dis . 2013 Aug; 23(5):855-60. PMID: 23954609
Background: Intravenous (IV) tissue plasminogen activator remains the only approved therapy for acute ischemic stroke (AIS) in the United States; however, less than 10% of patients receive treatment. This is...
9.
Reversal of the neurological deficit in acute stroke with the signal of efficacy trial of auto-BPAP to limit damage from suspected sleep apnea (Reverse-STEAL): study protocol for a randomized controlled trial
Kepplinger J, Barlinn K, Kolieskova S, Shahripour R, Pallesen L, Schrempf W, et al.
Trials . 2013 Aug; 14:252. PMID: 23941576
Background: Although the negative impact of sleep apnea on the clinical course of acute ischemic stroke (AIS) is well known, data regarding non-invasive ventilation in acute patients are scarce. Several...
10.
Systemic inflammatory response syndrome in tissue-type plasminogen activator-treated patients is associated with worse short-term functional outcome
Boehme A, Kapoor N, Albright K, Lyerly M, Rawal P, Bavarsad Shahripour R, et al.
Stroke . 2013 May; 44(8):2321-3. PMID: 23704110
Background And Purpose: Systemic inflammatory response syndrome (SIRS) is a generalized inflammatory state. The primary goal of the study was to determine whether differences exist in outcomes in SIRS and...